US 11229700
Trispecific molecule combining specific tumor targeting and local immune checkpoint inhibition
granted A61KA61K39/39541A61K39/3955
Quick answer
US patent 11229700 (Trispecific molecule combining specific tumor targeting and local immune checkpoint inhibition) held by Ludwig-Maximilians-Universitat Munchen expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ludwig-Maximilians-Universitat Munchen
- Grant date
- Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K39/39541, A61K39/3955, A61K39/39558, A61K39/39566